These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20616583)

  • 1. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.
    Kudo M; Hatanaka K; Maekawa K
    Oncology; 2010 Jul; 78 Suppl 1():40-5. PubMed ID: 20616583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
    Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
    Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma.
    Kudo M; Hatanaka K; Inoue T; Maekawa K
    Oncology; 2010 Jul; 78 Suppl 1():60-7. PubMed ID: 20616586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
    Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
    AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
    Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
    Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
    Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K
    J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.
    Maruyama H; Takahashi M; Ishibashi H; Okugawa H; Okabe S; Yoshikawa M; Yokosuka O
    Liver Int; 2009 May; 29(5):708-14. PubMed ID: 18803588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
    Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN
    J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.
    Korenaga K; Korenaga M; Furukawa M; Yamasaki T; Sakaida I
    J Gastroenterol; 2009; 44(7):733-41. PubMed ID: 19387532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma.
    Goto E; Masuzaki R; Tateishi R; Kondo Y; Imamura J; Goto T; Ikeda H; Akahane M; Shiina S; Omata M; Yoshida H; Koike K
    J Gastroenterol; 2012 Apr; 47(4):477-85. PubMed ID: 22200940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma.
    Dohmen T; Kataoka E; Yamada I; Miura K; Ohshima S; Shibuya T; Segawa D; Sato W; Anezaki Y; Ishii H; Kamada K; Goto T; Ohnishi H
    Intern Med; 2012; 51(1):1-7. PubMed ID: 22214616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
    Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
    Eur Radiol; 2024 Jun; 34(6):3795-3812. PubMed ID: 37989916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
    Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
    J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection.
    Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y; Terae S; Shirato H
    Jpn J Radiol; 2009 May; 27(4):185-93. PubMed ID: 19499310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
    Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
    Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.
    Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Zhou X; Tanaka K
    Eur J Radiol; 2009 Dec; 72(3):425-31. PubMed ID: 18930616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Luo W; Numata K; Morimoto M; Oshima T; Ueda M; Okada M; Takebayashi S; Zhou X; Tanaka K
    Eur J Radiol; 2010 Jul; 75(1):91-7. PubMed ID: 19361941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
    Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
    BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic imaging of hepatocellular carcinoma: recent progress.
    Kudo M
    Oncology; 2011; 81 Suppl 1():73-85. PubMed ID: 22212940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography.
    Makino Y; Imai Y; Ohama H; Igura T; Kogita S; Sawai Y; Fukuda K; Takamura M; Ohashi H; Murakami T
    Oncology; 2013; 84 Suppl 1():44-50. PubMed ID: 23428858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.